Search Results

Feb 19, 2026, 12:20 ET Antivenom Market to Reach $691.0 Million, Globally, by 2033 at 6.7% CAGR: Allied Market Research

supportive regulatory frameworks, government & NGO initiatives, increase in healthcare investments, rise in awareness & education, and surge in R&D initiatives. These factors collectively contribute to the enhanced availability, accessibility, and effectiveness of antivenom products, addressing

More news about: Allied Market Research

Feb 19, 2026, 11:53 ET Verana Health Introduces Industry First End-to-End Urologic-Oncology Datasets to Support Research

prostate cancers," said CK Wang, M.D., General Manager of Oncology and Chief Medical Officer, Verana Health. "This in turn is fueling the need for R&D by life science organizations and the need for a greater understanding of these diseases and outcomes based on longitudinal RWD."Researchers

More news about: Verana Health

Feb 19, 2026, 11:52 ET James R. Downing, MD, to step down as president and CEO of St. Jude Children's Research Hospital in late 2026

James R. Downing, MD, will step down as president and CEO in late 2026 as part of a planned leadership transition. He will move into a faculty role in the

More news about: St. Jude Children's Research Hospital

Feb 19, 2026, 11:48 ET /C O R R E C T I O N -- Burn Boot Camp/

More news about: Burn Boot Camp

Feb 19, 2026, 11:32 ET Curi Advisory Launches Revenue Cycle Solutions, Establishing Managed Solutions Offerings for Healthcare Organizations

announced the launch of Revenue Cycle Solutions, a new offering designed to help hospitals and physician practices simplify insurance accounts receivable (A/R) resolution, optimize cash collections, accelerate cash flow, and improve both financial and patient experience outcomes. This launch reinforces Curi

More news about: Curi

Feb 19, 2026, 11:00 ET Kimberly-Clark Highlights Generational Value Creation Opportunity at 2026 CAGNY Conference

Kimberly-Clark is meeting well-defined consumer needs with science-backed solutions that are redefining top-tier performance in personal care. The company's R&D organization has been re-wired to deliver at speed and scale across markets and segments to help drive profitable, innovation-led growth and elevate

More news about: Kimberly-Clark Corporation

Feb 19, 2026, 10:58 ET /C O R R E C T I O N -- inKind/

More news about: inKind

Feb 19, 2026, 10:30 ET Veterinary Contract Manufacturing & Research Market worth $9.24 billion by 2031 | MarketsandMarkets™

reproducibility, and regulatory compliance. Collectively, these developments are enhancing operational performance and promoting broader adoption of outsourced R&D and manufacturing services within the veterinary health sector.By product type, the medicines segment accounted for the largest market share

More news about: MarketsandMarkets

Feb 19, 2026, 10:16 ET Automotive Composites Market to Reach USD 14.7 Billion by 2033, at 4.2% CAGR, Says Allied Market Research

thermoset composites used in structural, exterior, interior and EV-specific components.Their core strategies focus on material innovation and R&D to develop lighter, stronger and more sustainable composites, including bio-based and recyclable materials that align with automaker emission and EV

More news about: Allied Market Research

Feb 19, 2026, 10:03 ET Bybit EU poszerza dostęp do USDC i EURC dzięki nowym kampaniom obejmującym stablecoiny w Europie

w platformie usług regulowanych.WIEDEŃ, 19 lutego 2026 r. /PRNewswire/ --

More news about: Bybit

Feb 19, 2026, 10:00 ET The Conference Board Leading Economic Index® (LEI) for the US Continued to Decline in December

r97.8r

More news about: The Conference Board

Feb 19, 2026, 10:00 ET Adiuvo Diagnostic's Indian Patent No. 323440 has been revoked by India's Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM)

technology development and clinical validation," says Anil Amlani, MolecuLight's CEO. "MolecuLight is committed to protecting these investments in R&D, and to bringing novel technologies to clinicians for the ultimate benefit of improved patient care. We respect the patent systems in place around

More news about: MolecuLight Corp.

Feb 19, 2026, 09:30 ET Adria News S.à r.l. launches Adria News Network, an independent brand serving Southeast Europe

Group.Comprised of world-class directors with deep international experience in media, governance and regulatory standards, the Board is chaired by Rani R. Raad. Rani's experience spans more than 25 years, with roles including President of CNN Commercial Worldwide, CEO of International Media Investments

More news about: Adria News Network

Feb 19, 2026, 09:00 ET HITRUST 2025 H2 Threat Analysis Confirms HITRUST Assessments Continue to Mitigate Top Attack Techniques as Adversaries Accelerate Use of AI-Driven Tactics

2025 H2 Cyber Threat Adaptive (CTA) Report, providing new evidence that HITRUST's continuously updated e1, i1, and r2 assessments portfolio remains highly effective at mitigating the top adversarial techniques used across real-world attacks in 2025. The second-half analysis

More news about: HITRUST Services Corp.

Feb 19, 2026, 09:00 ET Norm Ai and Microsoft: Legal & Compliance AI Built for the Way Work Actually Happens

expertise. Norm Ai has raised more than $140 million, backed by Blackstone, Bain Capital, Vanguard, Citi, New York Life, TIAA, Coatue, Craft Ventures, Henry R. Kravis, and Marc Benioff.For more information, visit 

More news about: Norm Ai

Feb 19, 2026, 09:00 ET Uranium Demand Continues to Rise as AI Power Demand Rewrites the Nuclear Playbook

Combination, including the approval of the A&R Merger Agreement by the shareholders of SVII and the receipt of regulatory approvals; (iv) market risks; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the A&R Merger Agreement; (vi) the effect of

More news about: Equity Insider

Feb 19, 2026, 09:00 ET Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

Liver Disease: basic Pathogerenic Mechanisms in the Progression from NAFLD to NASH. Transplantation, 103(1): p e1-e13, 2019.Ewsome PN and Loomba R. Therapeutic horizons in metabolic dysfunction–associated steatohepatitis. J Clin Invest.135(13):e186425; 2025.GENFIT: Announces Results from

More news about: Devonian Health Group Inc.

Feb 19, 2026, 08:37 ET Chiffre d'affaires et ventes records pour TEMSA sur les principaux marchés européens

confirme sa position parmi les fournisseurs de mobilité électrique les plus complets du secteur.S'appuyant sur près de vingt ans d'expérience en R & D dans le domaine de l'électrification et sur son installation interne d'assemblage de batteries, l'entreprise conçoit et développe ses propres

More news about: TEMSA